Friday, May 1, 2026

COWARDLY Consensus: US and Korea DUCK The Nuclear Submarine Crisis, Pretending ‘Political Trust’ Solves Global War

South Korea and China discuss nuclear submarines at APEC summit, with China opposing South Korea's plans for denuclearization.

Trump’s Exit Strategy: How It Could Boost Asian Markets Amid Ongoing Tensions

iM Securities predicts a rebound in South Korea's stock market due to Trump's exit strategy from the Iran conflict, despite ongoing tensions.

North Korea Fires Up Tensions: Missile Test Sparks Global Outcry

On the 26th, the United States, South...

Tag: cancer

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

GreenVet Announces CaniCancer-FFPE, a Precision Cancer Diagnostic Solution for Pets

GreenVet introduces CaniCancer, a unified cancer diagnostic solution for pets, streamlining biopsy and genetic testing for faster treatment.

Microgravity in Space May Revolutionize How Biopharmaceuticals Form and Function within the Body

Space's microgravity could transform biopharmaceuticals, enabling new treatments and technologies for diseases, emphasizing long-term research.

How to Detect Bile Duct Cancer: Jaundice, Itching, Abdominal Pain, and Weight Loss

Cholangiocarcinoma, or bile duct cancer, has a poor prognosis due to late detection; early diagnosis is crucial for better outcomes.

GIST Maps Out the Cascade of Cellular Interactions During Early Stages of Lung Cancer

South Korean researchers unveil how mutated cells create a cancer-friendly environment in early lung cancer, paving the way for early interventions.

SCL Group Partners with Indonesian Hospital to Expand Into Southeast Asia

SCL Group partners with Indonesia's RSCM Hospital to expand Korean-style precision diagnostics in Southeast Asia, focusing on cancer screening and AI solutions.

Unlocking Cancer Treatment: Celltrion’s 4 Promising ADC Drugs Enter Patient Trials in 2026

Celltrion's ADC cancer drug candidates CT-P70, CT-P71, and CT-P73 enter patient dosing, targeting various cancers with Fast Track Designation.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Celltrion sees prescription growth for key products in Europe, raises expectations for high-margin new drugs

Celltrion's cancer and autoimmune disease treatments are achieving stable growth in Europe, expanding their market influence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.